Holen Sie sich die Stockscreener-App
2.80
3.54%
-0.1028
Handel nachbörslich:
2.84
0.04
+1.43%
Schlusskurs vom Vortag:
$2.9028
Offen:
$2.97
24-Stunden-Volumen:
94,443
Relative Volume:
0.12
Marktkapitalisierung:
$4.58M
Einnahmen:
$4.79M
Nettoeinkommen (Verlust:
$-13.42M
KGV:
-1.0526
EPS:
-2.66
Netto-Cashflow:
$-10.30M
1W Leistung:
-6.98%
1M Leistung:
-18.60%
6M Leistung:
-34.12%
1J Leistung:
-77.84%
1-Tages-Spanne:
$2.735
$2.97
1-Wochen-Bereich:
$2.735
$3.29
52-Wochen-Spanne:
$2.735
$13.50
Qualigen Therapeutics Inc Stock (QLGN) Company Profile
Firmenname
Qualigen Therapeutics Inc
Sektor
Branche
Telefon
(760) 918-9165
Adresse
2042 CORTE DEL NOGAL, CALIFORNIA
Vergleichen Sie QLGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QLGN
Qualigen Therapeutics Inc
|
2.80 | 4.75M | 4.79M | -13.42M | -10.30M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Qualigen Therapeutics Inc Aktie (QLGN) Neueste Nachrichten
Qualigen Therapeutics Inc. Stock Analysis and ForecastMassive portfolio appreciation - PrintWeekIndia
What drives Qualigen Therapeutics Inc. stock priceExplosive trading opportunities - PrintWeekIndia
What analysts say about Qualigen Therapeutics Inc. stock outlookTriple-digit wealth increases - jammulinksnews.com
What makes Qualigen Therapeutics Inc. stock price move sharplyLong Term Low Risk Growth - Newser
Is Qualigen Therapeutics Inc. a good long term investmentConsistent double returns - jammulinksnews.com
What analysts say about Qualigen Therapeutics Inc. stockRapid-fire capital growth - jammulinksnews.com
Qualigen Therapeutics, Inc. SEC 10-Q Report - TradingView
3 Penny Stocks to Watch: Aptorum Group, Qualigen Therapeutics, and Incannex Healthcare Ltd. - AInvest
Biotech Stocks To Follow Now – July 16th - Defense World
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
why did qualifies go down to 3 dollars from 14 last year? and do the patent go well - AInvest
What caused QLGN's Q3 2023 earnings to miss forecasts? - AInvest
Qualigen Therapeutics Surges to 378th Most Traded Stock with $28.1 Million Turnover Amidst Patent Milestone - AInvest
Qualigen Therapeutics Inc’s Shares Reel: 39.68% Quarterly Revenue Decline Amid 7.08M Market Cap - investchronicle.com
Qualigen Therapeutics Soars on Patent Powerhouse News: What’s Driving QLGN’s Big Move? - RagingBull
Qualigen Therapeutics Soars 66%: Is the Biotech Breakout Sustainable? - AInvest
Qualigen’s Unexpected Surge: What Lies Ahead? - StocksToTrade
Qualigen Therapeutics Secures Global Patents for QN-302 - TipRanks
Qualigen Therapeutics stock soars after patent grants across 25 countries By Investing.com - Investing.com Canada
QLGN Stocks: A Rollercoaster of Trends? - timothysykes.com
Qualigen Therapeutics secures global patents for cancer drug QN-302 By Investing.com - Investing.com India
Qualigen Therapeutics secures global patents for cancer drug QN-302 - Investing.com
Qualigen Granted New Patents Covering 25 Countries - GlobeNewswire
Tecogen Inc (TGEN) Stock: Navigating a Year of Stock Volatility - investchronicle.com
Is It Worth Buying ESN(ethersocial)Watchlist Winner Update - Newser
How Qualigen Therapeutics Inc. stock performs during market volatilityExplosive Growth Potential - Newser
How Neumora Therapeutics Inc. stock performs during market volatilityCarefully Curated High Return Stocks - Newser
How BWFG stock performs during market volatilityMomentum Buy Alert - Newser
Why Qualigen Therapeutics Inc. stock attracts strong analyst attentionSafe High Return Entry Points - Newser
What makes Mfs Active Exchange Traded Funds Trust stock price move sharplySmart Money Trade Setups - Newser
Pre-market Movers: KAPA, CYCC, SONN, RANI... - RTTNews
Why RCAT stock attracts strong analyst attentionFree Predictions - Newser
Finanzdaten der Qualigen Therapeutics Inc-Aktie (QLGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):